Combined Stimulation of IL-2 and 4-1BB Receptors Augments the Antitumor Activity of E7 DNA Vaccines by Increasing Ag-Specific CTL Responses

Combined stimulation of TLR9 and 4.1BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTL activity and infiltration into tumor sites

(2012) Jeong-Im Sin et al.   CANCER LETTERS

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

(2012) Kyung Hee Noh et al.   JOURNAL OF CLINICAL INVESTIGATION

Cutting Edge: The Role of IFN-  Receptor and MyD88 Signaling in Induction of IL-15 Expression In Vivo

(2012) S. L. Colpitts et al.   JOURNAL OF IMMUNOLOGY

Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses

(2011) Shannon E. Smith et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Antitumor Therapeutic and Antimetastatic Activity of Electroporation-Delivered Human Papillomavirus 16 E7 DNA Vaccines: A Possible Mechanism for Enhanced Tumor Control

(2011) In Hee Lee et al.   DNA AND CELL BIOLOGY

Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation

(2011) H. J. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Promises and challenges of human papillomavirus vaccines for cervical cancer

(2008) Jeong-Im Sin   Expert Review of Anticancer Therapy

Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates

(2008) Adam J. Simon et al.   VACCINE